Jeri Kay Sandvick

Title: Jeri Kay Sandvick: Innovator in Saponin Research

Introduction

Jeri Kay Sandvick is a prominent inventor based in Hamilton, Montana, known for her significant contributions to the field of saponin research. With a total of four patents to her name, she has made remarkable advancements in the extraction and purification of saponin extracts, which have important applications in vaccine development.

Latest Patents

Sandvick's latest patents include innovative methods for saponin purification and extraction. One of her notable patents focuses on saponin extracts containing at least 93% QS-21 main peak and 0.25-3% 2018 component, as measured by UV absorbance at 214 nm. This patent outlines methods for making these extracts and their use as vaccine adjuvants. Another patent details crude aqueous extracts of Molina that contain the QS-21 main peak and the 2018 component, with a specific ratio of 2018 component to QS-21 main peak. This work emphasizes the importance of precise measurements in the extraction process.

Career Highlights

Sandvick is currently associated with GlaxoSmithKline Biologicals SA, where she continues to push the boundaries of research in her field. Her work has not only contributed to scientific knowledge but also has practical implications for vaccine development and public health.

Collaborations

Throughout her career, Sandvick has collaborated with esteemed colleagues, including Ahmad Taimour Baig and Juan Jose Diaz Garcia. These collaborations have fostered a rich environment for innovation and have led to the successful development of her patented technologies.

Conclusion

Jeri Kay Sandvick's contributions to saponin research exemplify the impact of innovative thinking in the field of biotechnology. Her patents and ongoing work at GlaxoSmithKline Biologicals SA highlight her role as a leading inventor in the industry.